Symptoms of overdose include confusion, drowsiness (severe), high blood pressure, increased sensitivity of eyes or skin to light, irregular, fast, or slow heartbeat, and unusually large amount of urine or increased frequency of urination.
Calcium supplements such as calcium gluceptate are taken by individuals who are unable to get enough calcium in their regular diet or who have a need for more calcium. They are used to prevent or treat several conditions that may cause hypocalcemia (not enough calcium in the blood). The body needs calcium to make strong bones. Calcium is also needed for the heart, muscles, and nervous system to work properly.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Ceftriaxone | The risk or severity of adverse effects can be increased when Calcium glucoheptonate is combined with Ceftriaxone. |
| Deferiprone | The serum concentration of Deferiprone can be decreased when it is combined with Calcium glucoheptonate. |
| Dobutamine | The therapeutic efficacy of Dobutamine can be decreased when used in combination with Calcium glucoheptonate. |
| Dolutegravir | The serum concentration of Dolutegravir can be decreased when it is combined with Calcium glucoheptonate. |
| Eltrombopag | The serum concentration of Eltrombopag can be decreased when it is combined with Calcium glucoheptonate. |
| Estramustine | Calcium glucoheptonate can cause a decrease in the absorption of Estramustine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Calcium acetate | The risk or severity of adverse effects can be increased when Calcium glucoheptonate is combined with Calcium acetate. |
| Digoxin | Calcium glucoheptonate may increase the arrhythmogenic and cardiotoxic activities of Digoxin. |
| Acetyldigitoxin | Calcium glucoheptonate may increase the arrhythmogenic and cardiotoxic activities of Acetyldigitoxin. |
| Deslanoside | Calcium glucoheptonate may increase the arrhythmogenic and cardiotoxic activities of Deslanoside. |
| Ouabain | Calcium glucoheptonate may increase the arrhythmogenic and cardiotoxic activities of Ouabain. |
| Digitoxin | Calcium glucoheptonate may increase the arrhythmogenic and cardiotoxic activities of Digitoxin. |
| Oleandrin | Calcium glucoheptonate may increase the arrhythmogenic and cardiotoxic activities of Oleandrin. |
| Cymarin | Calcium glucoheptonate may increase the arrhythmogenic and cardiotoxic activities of Cymarin. |
| Proscillaridin | Calcium glucoheptonate may increase the arrhythmogenic and cardiotoxic activities of Proscillaridin. |
| Metildigoxin | Calcium glucoheptonate may increase the arrhythmogenic and cardiotoxic activities of Metildigoxin. |
| Lanatoside C | Calcium glucoheptonate may increase the arrhythmogenic and cardiotoxic activities of Lanatoside C. |
| Gitoformate | Calcium glucoheptonate may increase the arrhythmogenic and cardiotoxic activities of Gitoformate. |
| Acetyldigoxin | Calcium glucoheptonate may increase the arrhythmogenic and cardiotoxic activities of Acetyldigoxin. |
| Peruvoside | Calcium glucoheptonate may increase the arrhythmogenic and cardiotoxic activities of Peruvoside. |
| Grepafloxacin | Calcium glucoheptonate can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Enoxacin | Calcium glucoheptonate can cause a decrease in the absorption of Enoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Pefloxacin | Calcium glucoheptonate can cause a decrease in the absorption of Pefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Ciprofloxacin | Calcium glucoheptonate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Trovafloxacin | Calcium glucoheptonate can cause a decrease in the absorption of Trovafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Nalidixic acid | Calcium glucoheptonate can cause a decrease in the absorption of Nalidixic acid resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Rosoxacin | Calcium glucoheptonate can cause a decrease in the absorption of Rosoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Cinoxacin | Calcium glucoheptonate can cause a decrease in the absorption of Cinoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Lomefloxacin | Calcium glucoheptonate can cause a decrease in the absorption of Lomefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Gatifloxacin | Calcium glucoheptonate can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Norfloxacin | Calcium glucoheptonate can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Gemifloxacin | Calcium glucoheptonate can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Ofloxacin | Calcium glucoheptonate can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Sparfloxacin | Calcium glucoheptonate can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Temafloxacin | Calcium glucoheptonate can cause a decrease in the absorption of Temafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Fleroxacin | Calcium glucoheptonate can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Technetium Tc-99m ciprofloxacin | Calcium glucoheptonate can cause a decrease in the absorption of Technetium Tc-99m ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Garenoxacin | Calcium glucoheptonate can cause a decrease in the absorption of Garenoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Nemonoxacin | Calcium glucoheptonate can cause a decrease in the absorption of Nemonoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Flumequine | Calcium glucoheptonate can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Enrofloxacin | Calcium glucoheptonate can cause a decrease in the absorption of Enrofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Orbifloxacin | Calcium glucoheptonate can cause a decrease in the absorption of Orbifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Sarafloxacin | Calcium glucoheptonate can cause a decrease in the absorption of Sarafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Difloxacin | Calcium glucoheptonate can cause a decrease in the absorption of Difloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Pazufloxacin | Calcium glucoheptonate can cause a decrease in the absorption of Pazufloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Prulifloxacin | Calcium glucoheptonate can cause a decrease in the absorption of Prulifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Delafloxacin | Calcium glucoheptonate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Sitafloxacin | Calcium glucoheptonate can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Oxolinic acid | Calcium glucoheptonate can cause a decrease in the absorption of Oxolinic acid resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Rufloxacin | Calcium glucoheptonate can cause a decrease in the absorption of Rufloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Pipemidic acid | Calcium glucoheptonate can cause a decrease in the absorption of Pipemidic acid resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Strontium ranelate | The serum concentration of Strontium ranelate can be decreased when it is combined with Calcium glucoheptonate. |
| Doxycycline | The serum concentration of Doxycycline can be decreased when it is combined with Calcium glucoheptonate. |
| Lymecycline | The serum concentration of Lymecycline can be decreased when it is combined with Calcium glucoheptonate. |
| Clomocycline | The serum concentration of Clomocycline can be decreased when it is combined with Calcium glucoheptonate. |
| Oxytetracycline | The serum concentration of Oxytetracycline can be decreased when it is combined with Calcium glucoheptonate. |
| Demeclocycline | The serum concentration of Demeclocycline can be decreased when it is combined with Calcium glucoheptonate. |
| Tetracycline | The serum concentration of Tetracycline can be decreased when it is combined with Calcium glucoheptonate. |
| Metacycline | The serum concentration of Metacycline can be decreased when it is combined with Calcium glucoheptonate. |
| Minocycline | The serum concentration of Minocycline can be decreased when it is combined with Calcium glucoheptonate. |
| Sarecycline | The serum concentration of Sarecycline can be decreased when it is combined with Calcium glucoheptonate. |
| Omadacycline | The serum concentration of Omadacycline can be decreased when it is combined with Calcium glucoheptonate. |
| Penimepicycline | The serum concentration of Penimepicycline can be decreased when it is combined with Calcium glucoheptonate. |
| Methyclothiazide | Methyclothiazide may decrease the excretion rate of Calcium glucoheptonate which could result in a higher serum level. |
| Chlorthalidone | Chlorthalidone may decrease the excretion rate of Calcium glucoheptonate which could result in a higher serum level. |
| Bendroflumethiazide | Bendroflumethiazide may decrease the excretion rate of Calcium glucoheptonate which could result in a higher serum level. |
| Metolazone | Metolazone may decrease the excretion rate of Calcium glucoheptonate which could result in a higher serum level. |
| Benzthiazide | Benzthiazide may decrease the excretion rate of Calcium glucoheptonate which could result in a higher serum level. |
| Hydroflumethiazide | Hydroflumethiazide may decrease the excretion rate of Calcium glucoheptonate which could result in a higher serum level. |
| Indapamide | Indapamide may decrease the excretion rate of Calcium glucoheptonate which could result in a higher serum level. |
| Chlorothiazide | Chlorothiazide may decrease the excretion rate of Calcium glucoheptonate which could result in a higher serum level. |
| Hydrochlorothiazide | Hydrochlorothiazide may decrease the excretion rate of Calcium glucoheptonate which could result in a higher serum level. |
| Trichlormethiazide | Trichlormethiazide may decrease the excretion rate of Calcium glucoheptonate which could result in a higher serum level. |
| Polythiazide | Polythiazide may decrease the excretion rate of Calcium glucoheptonate which could result in a higher serum level. |
| Quinethazone | Quinethazone may decrease the excretion rate of Calcium glucoheptonate which could result in a higher serum level. |
| Cyclopenthiazide | Cyclopenthiazide may decrease the excretion rate of Calcium glucoheptonate which could result in a higher serum level. |
| Epitizide | Epitizide may decrease the excretion rate of Calcium glucoheptonate which could result in a higher serum level. |
| Triethylenetetramine | Calcium glucoheptonate can cause a decrease in the absorption of Triethylenetetramine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Calcitriol | The risk or severity of adverse effects can be increased when Calcitriol is combined with Calcium glucoheptonate. |
| Calcifediol | The risk or severity of adverse effects can be increased when Calcifediol is combined with Calcium glucoheptonate. |
| Ergocalciferol | The risk or severity of adverse effects can be increased when Ergocalciferol is combined with Calcium glucoheptonate. |
| Cholecalciferol | The risk or severity of adverse effects can be increased when Cholecalciferol is combined with Calcium glucoheptonate. |
| Paricalcitol | The risk or severity of adverse effects can be increased when Paricalcitol is combined with Calcium glucoheptonate. |
| Dihydrotachysterol | The risk or severity of adverse effects can be increased when Dihydrotachysterol is combined with Calcium glucoheptonate. |
| Alfacalcidol | The risk or severity of adverse effects can be increased when Alfacalcidol is combined with Calcium glucoheptonate. |
| Calcipotriol | The risk or severity of adverse effects can be increased when Calcipotriol is combined with Calcium glucoheptonate. |
| Seocalcitol | The risk or severity of adverse effects can be increased when Seocalcitol is combined with Calcium glucoheptonate. |
| Inecalcitol | The risk or severity of adverse effects can be increased when Inecalcitol is combined with Calcium glucoheptonate. |
| Becocalcidiol | The risk or severity of adverse effects can be increased when Becocalcidiol is combined with Calcium glucoheptonate. |
| Eldecalcitol | The risk or severity of adverse effects can be increased when Eldecalcitol is combined with Calcium glucoheptonate. |
| 1alpha,24S-Dihydroxyvitamin D2 | The risk or severity of adverse effects can be increased when 1alpha,24S-Dihydroxyvitamin D2 is combined with Calcium glucoheptonate. |
| Elocalcitol | The risk or severity of adverse effects can be increased when Elocalcitol is combined with Calcium glucoheptonate. |
| Maxacalcitol | The risk or severity of adverse effects can be increased when Maxacalcitol is combined with Calcium glucoheptonate. |
| Doxercalciferol | The risk or severity of adverse effects can be increased when Doxercalciferol is combined with Calcium glucoheptonate. |
| Vitamin D | The risk or severity of adverse effects can be increased when Vitamin D is combined with Calcium glucoheptonate. |
| 1alpha-Hydroxyvitamin D5 | The risk or severity of adverse effects can be increased when 1alpha-Hydroxyvitamin D5 is combined with Calcium glucoheptonate. |
| Tacalcitol | The risk or severity of adverse effects can be increased when Tacalcitol is combined with Calcium glucoheptonate. |
| Previtamin D(3) | The risk or severity of adverse effects can be increased when Previtamin D(3) is combined with Calcium glucoheptonate. |
| Isradipine | The therapeutic efficacy of Isradipine can be decreased when used in combination with Calcium glucoheptonate. |
| Diltiazem | The therapeutic efficacy of Diltiazem can be decreased when used in combination with Calcium glucoheptonate. |